questcor pharmaceuticals inc

StreetInsider.com Pre-Open Movers: Jackson Hewitt Tax Service Inc. (NYSE: JTX) 23% LOWER; reports Q3 EPS of $0.61, which may not compare to the consensus of $0.99.

Revenues came in at $97.6 million, versus the consensus of $118.35 million. Sees FY adjusted EPS of $1.48-$1.60, which may not compare to the consensus of $2.08.

Sees FY revenues of $282-$292 million, versus the consensus of $309.9 million. Questcor Pharmaceuticals, Inc.

(AMEX: QSC) 17.3% HIGHER; reports Q4 EPS of $0.45 compared to a $0.06 loss for the same period last year.

Questcor Pharmaceuticals, Inc. (AMEX: QSC) 17.3% HIGHER; reports Q4 EPS of $0.45 compared to a $0.06 loss for the same period last year.

Revenues were $27.1 million for Q4 compared to $3.4 million for the same period last year. Separately, the QSC board approves the repurchase plan for up to 7 million shares.

Obagi Medical Products, Inc. (NASDAQ: OMPI) 12% LOWER; reports Q4 EPS of $0.21, cents better than the analyst estimate of $0..

Revenues for the quarter were $27.3 million, versus the consensus of $ million.